Thomas W. Beetham, EVP & Chief Legal Officer at Kiniksa Pharmaceuticals, Ltd. (KNSA), sold 59,178 shares at $25.84 ($1.5M) on 2020-07-01, disclosed to the SEC on 2020-07-02.
Open-market sale of $1.5M KNSA by EVP & Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.32 | 26,734 | $677K | 45.1% |
| 2 | $25.32 | 26,734 | $677K | 45.1% |
| 3 | $25.84 | 2,855 | $74K | 4.9% |
| 4 | $25.84 | 2,855 | $74K | 4.9% |
| Total | $25.37 avg | 59,178 | $1.5M | 100% |
| Filing → |
| KNSA | SELL | 2021-02-05 | $109K | — | Filing → |
| KNSA | SELL | 2020-06-12 | $690K | — | Filing → |
| KNSA | SELL | 2020-04-22 | $1.9M | — | Filing → |